Pakistan might be accepting the Pfizer-BioNTech vaccine in the first quarter of the year under the World Health Organization’s COVAX project.
The worldwide activity consented to a development buy arrangement with American pharmaceutical for up to 40 million doses of the Pfizer-BioNTech Covid vaccine competitor – which has just been affirmed for crisis use by the global health body.
A statement gave a week ago read that the vaccine rollout will begin with the “fruitful exchange and execution of supply arrangements.
COVAX additionally affirmed it would get initial 100 million dosages of the Oxford-Astrazeneca vaccine made by the Serum Institute of India (SII) under a current concurrence with the Indian firm.
“Of these initial 100 million dosages, the larger part is reserved for delivery in the primary quarter of the year, pending WHO Emergency Use Listing,” read the statement.
Being Helper is not responsible for content on external links.